Provider information / Impressum

The Affibody website is provided by Affibody Medical AB and subsidiaries. A company organized under the laws of Sweden. Affibody Medical AB is commercially registered in Solna, Sweden. Company organizational number 556714-5601, Affibody Medical AB, is a holding of Patricia Industries.

CEO: David Bejker
Address: Scheeles väg 2, SE-171 65 Solna, Sweden,
E-post: reception@affibody.com,
Tel: +46 (0)8 59 88 38 00

For more information regarding Affibody see:
About Affibody | Affibody AB

Responsible for content on the webpage: CEO David Bejker.

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Upcoming reports Financial calendar

  • Interim Report January to March 2020 (May 15, 2020)
  • Interim Report January to June 2020 (August 21, 2020)
  • Interim Report January to September 2020 (November 13, 2020)
  • Year End Report 2020 (February 2021)